SLN
Silence Therapeutics Plc ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.90
-0.07 ▼ -1.00%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$6.90
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.88 | Insider Own | 17.95% | Shs Outstand | 0.05B | Perf Week | 10.75% |
| Market Cap | 0.33B | Forward P/E | - | EPS next Y | -9.16% | Insider Trans | - | Shs Float | 0.04B | Perf Month | 59.35% |
| Enterprise Value | 0.24B | PEG | - | EPS next Q | -0.13 | Inst Own | 21.73% | Short Float | 4.01% | Perf Quarter | 10.22% |
| Income | -0.09B | P/S | 581.94 | EPS this Y | 15.08% | Inst Trans | -5.91% | Short Ratio | 5.64 | Perf Half Y | 41.39% |
| Sales | 0.00B | P/B | 5.23 | EPS next 5Y | -1.67% | ROA | - | Short Interest | 1.55M | Perf YTD | 13.49% |
| Book/sh | 1.32 | P/C | 3.83 | EPS past 3/5Y | -6.68% -4.2% | ROE | - | 52W High | -11.88% ($7.83) | Perf Year | 69.95% |
| Cash/sh | 1.8 | P/FCF | - | Sales past 3/5Y | -70.38% -39.7% | ROIC | -142.54% | 52W Low | 250.25% ($1.97) | Perf 3Y | -30.65% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -12.62% | Gross Margin | -14.42% | Volatility(W/M) | 11.05% 11.29% | Perf 5Y | -72.15% |
| Dividend TTM | - | EV/Sales | 430.24 | Sales Y/Y TTM | - | Oper. Margin | -14693.96% | ATR (14) | 0.61 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.72 | EPS Q/Q | 66.65% | Profit Margin | -15841.09% | RSI (14) | 70.25 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.72 | Sales Q/Q | -97.71% | SMA20 | 21.73% ($5.67) | Beta | 1.24 | Target Price | $32.8 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 27.06% ($5.43) | Rel Volume | 0.83 | Prev Close | $6.97 |
| Employees | 88 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 51.56% -98.66% | SMA200 | 19.12% ($5.79) | Avg Volume(3M) | 0.28M | Price | $6.9 |
| IPO | 2020/9/8 | Option/Short | Yes/Yes | Trades | 2415 | Volume | 227,468 | Change | -1% |
뉴스 로딩 중...